Trials / Completed
CompletedNCT02378337
Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 335 (actual)
- Sponsor
- Hospital Sao Rafael · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Identify the best combination of predictive variables that influence ionizing radiation dose and improved image quality through analysis and quantification of PET-CT images in simulators and patients.
Conditions
- Malignant Neoplasm of Breast
- Hodgkin Disease
- Non-Hodgkin Lymphoma, Follicular (Nodular)
- Malignant Neoplasm of Bronchus and Lung
- Malignant Neoplasm of Colon
- Secondary Neoplasm Malignant and Unspecified Lymph Nodes
- Malignant Melanoma of the Skin
- Malignant Neoplasm of Small Intestine
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Image quantify | Will be observed all patients who perform PET / CT examinations, independent of clinical indication, in nuclear medicine at Hospital Sao Rafael. Those who show interest in participating in the study, will be provided free and informed consent form (ICF) for your appreciation. This evaluation will serve for analysis and quantification of PET-CT images. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-08-01
- Completion
- 2016-03-01
- First posted
- 2015-03-04
- Last updated
- 2017-11-28
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02378337. Inclusion in this directory is not an endorsement.